Medicinal cannabis clinics fined over ads

The government regulator says the advertising included unapproved references to serious diseases or conditions including cancer and epilepsy. 

Some advertising also suggested or implied that particular medicinal cannabis products were recommended or approved by a government authority, the TGA said.

Prescription-only medications cannot be advertised to the public in Australia.

Australian Institute of Medicinal Cannabis was fined $106,560 and Biologics Research Institute Australia was fined $133,200.